Literature DB >> 20213621

Prevalence and causes of bilateral blindness and visual impairment among institutionalized elderly people in Pamplona, Spain.

Carmen Sainz-Gómez1, Patricia Fernández-Robredo, Angel Salinas-Alamán, Javier Moreno Montañés, José Maria Escudero Berasategui, Francisco Guillén-Grima, José María Ruiz-Moreno, Alfredo García-Layana.   

Abstract

PURPOSE: To estimate the prevalence and causes of bilateral blindness and visual impairment in an urban institutionalized population aged 65 years and older.
METHODS: A total of 392 nursing home residents completed a standardized eye examination, including measurement of visual acuity (VA), intraocular pressure, lens opacity grading, indirect ophthalmoscopy, and photography of the macular area. The major causes of vision loss identified for all participants were blindness and visual impairment.
RESULTS: The average subject age was 82 years (65-97); women outnumbered men 263 to 129. The prevalence of bilateral blindness (VA > or =1.0 logarithm of the minimum angle of resolution [logMAR]) was 14.9% (43/288); the prevalence of visual impairment (VA > or =0.5 and 1.0 logMAR) was 31.9% (92/288). Blindness and visual impairment increased significantly with age (p<0.05), odds ratio (OR) 1.047 and 1.088, respectively. Cataract was the most common cause of bilateral blindness and visual impairment (27.9% and 44.6%, respectively) followed by pathologic myopia (23.3%) and age-related macular degeneration (AMD) (20.9%) for blindness, and by AMD (27.2%) and pathologic myopia (12%) for visual impairment. Fifty percent of subjects with visual loss had the potential for improved vision with medical or surgical intervention.
CONCLUSIONS: Although the prevalences were high, these data are important since it is difficult for epidemiologic studies to include aged, institutionalized individuals, although their numbers are increasing. Recognition of the predominant causes of visual loss dependent on age is fundamental for early diagnosis and treatment of ocular diseases. Many cases of low vision can be treated with appropriate ophthalmologic care.

Entities:  

Mesh:

Year:  2010        PMID: 20213621     DOI: 10.1177/112067211002000228

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  14 in total

1.  Iris color and associated pathological ocular complications: a review of epidemiologic studies.

Authors:  Hong-Peng Sun; Yi Lin; Chen-Wei Pan
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

2.  Reconsideration of the most appropriate criterion in the lowest classification of vision disability in Japan.

Authors:  Tomomi Nishida; Noburo Ando; Kazushige Sado; Satoshi Nakadomari
Journal:  Jpn J Ophthalmol       Date:  2011-08-24       Impact factor: 2.447

3.  Social Engagement, Cognition, Depression, and Comorbidity in Nursing Home Residents With Sensory Impairment.

Authors:  Darina V Petrovsky; Justine S Sefcik; Alexandra L Hanlon; Alicia J Lozano; Pamela Z Cacchione
Journal:  Res Gerontol Nurs       Date:  2019-07-09       Impact factor: 1.571

4.  Change in foveal position based on age and axial length in high myopic eyes.

Authors:  Qian Zhang; Kaddie Kwok Chen; Wei-Feng Liu; Guo-Fu Huang
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

5.  The Frequency and Causes of Blindness in a Rural Region of Central Anatolia of Turkey.

Authors:  Enver Mirza; Gunsu Deniz Mirza; Refik Oltulu; Mehmet Okka; Ahmet Ozkagnici
Journal:  Eurasian J Med       Date:  2019-10

6.  A cross-sectional study of visual impairment in elderly population in residential care in the South Indian state of Andhra Pradesh: a cross-sectional study.

Authors:  Srinivas Marmamula; Chandra Sekhar L V Ravuri; Mei Ying Boon; Rohit C Khanna
Journal:  BMJ Open       Date:  2013-03-15       Impact factor: 2.692

Review 7.  Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration.

Authors:  Alfredo García-Layana; Marta S Figueroa; Luis Arias; Javier Araiz; José María Ruiz-Moreno; José García-Arumí; Francisco Gómez-Ulla; María Isabel López-Gálvez; Francisco Cabrera-López; José Manuel García-Campos; Jordi Monés; Enrique Cervera; Felix Armadá; Roberto Gallego-Pinazo
Journal:  J Ophthalmol       Date:  2015-09-27       Impact factor: 1.909

8.  Visual impairment and multimorbidity in a representative sample of the Spanish population.

Authors:  Noe Garin; Beatriz Olaya; Elvira Lara; Maria Victoria Moneta; Marta Miret; Jose Luis Ayuso-Mateos; Josep Maria Haro
Journal:  BMC Public Health       Date:  2014-08-08       Impact factor: 3.295

Review 9.  Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept.

Authors:  Alfredo García-Layana; Marta S Figueroa; Javier Araiz; José M Ruiz-Moreno; Francisco Gómez-Ulla; Luis Arias-Barquet; Nicholas Reiter
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

10.  Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients.

Authors:  Valentina Bilbao-Malavé; Sergio Recalde; Jaione Bezunartea; Maria Hernandez-Sanchez; Jorge González-Zamora; Leyre Maestre-Rellan; José María Ruiz-Moreno; Javier Araiz-Iribarren; Luis Arias; Jorge Ruiz-Medrano; Ignacio Flores-Moreno; Sara Llorente-González; Guillermo Fernández-Sanz; Clara Berrozpe-Villabona; Alvaro Velazquez-Villoria; Ester Carreño; Patricia Fernandez-Robredo; Alfredo Garcia-Layana
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.